TargetMol

TM6008

Product Code:
 
TAR-T26281
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T26281-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26281-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26281-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
TM6008 is an inhibitor of prolyl hydroxylase that protects against cell death after hypoxia.
CAS:
945008-17-3
Formula:
C21H17N5O3
Molecular Weight:
387.399
Purity:
0.98
SMILES:
Cn1c(N)c(C(=O)c2cc(nc3ccccc23)-c2ccccn2)c(=O)n(C)c1=O

References

1. Tada Y, Ogawa M, Watanabe R, Zempo H, Takamura C, Suzuki J, Dan T, Miyata T, Isobe M, Komuro I. Neovascularization induced by hypoxia inducible transcription factor is associated with the improvement of cardiac dysfunction in experimental autoimmune myocarditis. Expert Opin Investig Drugs. 2014 Feb;23(2):149-62. doi: 10.1517/13543784.2014.855196. Epub 2013 Nov 11. PubMed PMID: 24205804. 2. Kontani S, Nagata E, Uesugi T, Moriya Y, Fujii N, Miyata T, Takizawa S. A novel prolyl hydroxylase inhibitor protects against cell death after hypoxia. Neurochem Res. 2013 Dec;38(12):2588-94. doi: 10.1007/s11064-013-1175-0. Epub 2013 Oct 17. PubMed PMID: 24132642; PubMed Central PMCID: PMC3898357. 3. Takizawa S, Nagata E, Luo HR. [Novel neuroprotective agents: a HIF activator and an Akt activator]. Rinsho Shinkeigaku. 2012;52(11):911-2. Japanese. PubMed PMID: 23196464. 4. Takeda K, Ichiki T, Narabayashi E, Inanaga K, Miyazaki R, Hashimoto T, Matsuura H, Ikeda J, Miyata T, Sunagawa K. Inhibition of prolyl hydroxylase domain-containing protein suppressed lipopolysaccharide-induced TNF-alpha expression. Arterioscler Thromb Vasc Biol. 2009 Dec;29(12):2132-7. doi: 10.1161/ATVBAHA.109.196071. Epub 2009 Sep 17. PubMed PMID: 19762779.